Clinical Trial Update: Polyprenols (Ropren) in Acute Coronary Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating polyprenols (Ropren) in acute coronary syndrome has completed; results are not provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Ropren (polyprenols)

Snippet

Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED